These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 9198240

  • 1. Low molecular weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical results.
    Hirsh J, Crowther M.
    Thromb Haemost; 1997 Jul; 78(1):689-92. PubMed ID: 9198240
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.
    Hirsh J.
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):20-5. PubMed ID: 9399406
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J, Riess H, Büller HR, Brom J, Weidinger G, Huisman MV.
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of cancer-associated thrombosis: distinguishing among antithrombotic agents.
    Pruemer J.
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S26-39; quiz S41-2. PubMed ID: 16638458
    [Abstract] [Full Text] [Related]

  • 11. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD, Pineo GF, Stein P.
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [Abstract] [Full Text] [Related]

  • 12. Management of venous thromboembolic disease. The impact of low-molecular-weight heparin.
    Tapson VF, Hull RD.
    Clin Chest Med; 1995 Jun; 16(2):281-94. PubMed ID: 7656540
    [Abstract] [Full Text] [Related]

  • 13. Low molecular weight heparin: a critical analysis of clinical trials.
    Green D, Hirsh J, Heit J, Prins M, Davidson B, Lensing AW.
    Pharmacol Rev; 1994 Mar; 46(1):89-109. PubMed ID: 8190751
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive?
    Hull RD, Pineo GF.
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():11-23. PubMed ID: 15085462
    [Abstract] [Full Text] [Related]

  • 16. Low molecular weight heparins in the initial treatment of deep vein thrombosis.
    Volteas SK, Kalodiki E, Nicolaides AN.
    Int Angiol; 1996 Mar; 15(1):67-74. PubMed ID: 8739540
    [Abstract] [Full Text] [Related]

  • 17. Should low-molecular-weight heparins replace unfractionated heparin as the agent of choice for adults with deep venous thrombosis?
    Brewer D.
    J Fam Pract; 1998 Sep; 47(3):185-92. PubMed ID: 9752370
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
    Prandoni P, Simioni P, Pagnan A.
    Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
    [Abstract] [Full Text] [Related]

  • 20. Low-molecular-weight heparin in outpatient treatment of DVT.
    Yeager BF, Matheny SC.
    Am Fam Physician; 1999 Feb 15; 59(4):945-52. PubMed ID: 10068716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.